Understanding cooperativity in human P450 mediated drug-drug interactions

被引:20
|
作者
Sligar, Stephen G.
Denisov, Ilia G.
机构
[1] Univ Illinois, Dept Biochem, Coll Med, Urbana, IL 61801 USA
[2] Univ Illinois, Dept Chem, Coll Med, Urbana, IL 61801 USA
[3] Univ Illinois, Ctr Biophys & Comp Biol, Urbana, IL 61801 USA
关键词
cytochrome P450; CYP3A4; homotropic cooperativity; heterotropic cooperativity; dose-response function;
D O I
10.1080/03602530701498521
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Multiple drugs can interact, often leading to adverse side effects. One well documented site for these interactions includes the group of cytochrome P450 monoxygenases. Several human hepatic systems are known to bind more than a single substrate molecule which can give rise to the terms "homotropic and heterotopic cooperativity" to define the resultant thermodynamic and kinetic properties observed in drug metabolism in vestigations. We provide a means for understanding and quantitating these drug-drug interactions by documenting the functional properties of the various states of the enzyme and show that, even in the absence of true binding cooperativity, significant non-Michaelis metabolic profiles are possible.
引用
收藏
页码:567 / 579
页数:13
相关论文
共 50 条
  • [21] Clinically important pharmacokinetic drug-drug interactions: role of cytochrome P450 enzymes
    Tanaka, E
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1998, 23 (06) : 403 - 416
  • [22] Evaluation of drug-drug interaction potential of beraprost sodium mediated by P450 in vitro
    Fukazawa, Tominaga
    Yajima, Kanako
    Miyamoto, Yohei
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2008, 128 (10): : 1459 - 1465
  • [23] Antiplatelet Drug Resistance and Drug-Drug Interactions: Role of Cytochrome P450 3A4
    Wei C. Lau
    Paul A. Gurbel
    Pharmaceutical Research, 2006, 23 : 2691 - 2708
  • [24] Antiplatelet drug resistance and drug-drug interactions: Role of cytochrome p450 3A4
    Lau, Wei C.
    Gurbel, Paul A.
    PHARMACEUTICAL RESEARCH, 2006, 23 (12) : 2691 - 2708
  • [25] Drug-drug interactions: Effect of quinidine on nifedipine binding to human cytochrome P450 3A4
    Koley, AP
    Robinson, RC
    Markowitz, A
    Friedman, FK
    BIOCHEMICAL PHARMACOLOGY, 1997, 53 (04) : 455 - 460
  • [26] A Quantitative Approach to the Prediction of Drug-Drug Interactions Mediated by Cytochrome P450 2C8 Inhibition
    Di Paolo, Veronica
    Ferrari, Francesco Maria
    Poggesi, Italo
    Quintieri, Luigi
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2021, 17 (11) : 1345 - 1352
  • [27] The mechanisms of interactions of psychotropic drugs with liver and brain cytochrome P450 and their significance for drug effect and drug-drug interactions
    Daniel, Wladyslawa A.
    Bromek, Ewa
    Danek, Przemyslaw J.
    Haduch, Anna
    BIOCHEMICAL PHARMACOLOGY, 2022, 199
  • [28] Potential Cytochrome P450 Drug-Drug Interactions among Pediatric Patients Undergoing Tonsillectomy
    Faria, John
    Solverson, Matthew
    Faria, Madlin
    Benoit, Margo
    McCormick, Michael
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2019, 160 (01) : 145 - 149
  • [29] Mechanism-based inhibition of cytochrome P450 in vitro: Implications for drug-drug interactions
    Dilworth, C
    Abernethy, L
    Fenn, P
    DRUG METABOLISM REVIEWS, 2003, 35 : 28 - 28
  • [30] The role of metabolites in predicting drug-drug interactions: Focus on irreversible cytochrome P450 inhibition
    VandenBrink, Brooke M.
    Isoherranen, Nina
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2010, 13 (01) : 66 - 77